Literature DB >> 31727849

Exploring Care Attributes of Nephrologists Ranking Favorably on Measures of Value.

Brian M Brady1,2,3, Meera V Ragavan2,3, Melora Simon2, Glenn M Chertow4,3, Arnold Milstein2,3.   

Abstract

BACKGROUND: Despite growth in value-based payment, attributes of nephrology care associated with payer-defined value remains unexplored.
METHODS: Using national health insurance claims data from private preferred provider organization plans, we ranked nephrology practices using total cost of care and a composite of common quality metrics. Blinded to practice rankings, we conducted site visits at four highly ranked and three average ranked practices to identify care attributes more frequently present in highly ranked practices. A panel of nephrologists used a modified Delphi method to score each distinguishing attribute on its potential to affect quality and cost of care and ease of transfer to other nephrology practices.
RESULTS: Compared with average-value peers, high-value practices were located in areas with a relatively higher proportion of black and Hispanic patients and a lower proportion of patients aged >65 years. Mean risk-adjusted per capita monthly total spending was 24% lower for high-value practices. Twelve attributes comprising five general themes were observed more frequently in high-value nephrology practices: preventing near-term costly health crises, supporting patient self-care, maximizing effectiveness of office visits, selecting cost-effective diagnostic and treatment options, and developing infrastructure to support high-value care. The Delphi panel rated four attributes highly on effect and transferability: rapidly adjustable office visit frequency for unstable patients, close monitoring and management to preserve kidney function, early planning for vascular access, and education to support self-management at every contact.
CONCLUSIONS: Findings from this small-scale exploratory study may serve as a starting point for nephrologists seeking to improve on payer-specified value measures.
Copyright © 2019 by the American Society of Nephrology.

Entities:  

Keywords:  Economic Analysis; Economic Impact; chronic kidney disease; clinical nephrology; kidney disease; nephrology

Mesh:

Year:  2019        PMID: 31727849      PMCID: PMC6900798          DOI: 10.1681/ASN.2019030219

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  48 in total

1.  Clinical Risk Groups (CRGs): a classification system for risk-adjusted capitation-based payment and health care management.

Authors:  John S Hughes; Richard F Averill; Jon Eisenhandler; Norbert I Goldfield; John Muldoon; John M Neff; James C Gay
Journal:  Med Care       Date:  2004-01       Impact factor: 2.983

Review 2.  Support for self care for patients with chronic disease.

Authors:  Anne Kennedy; Anne Rogers; Peter Bower
Journal:  BMJ       Date:  2007-11-10

3.  Effectiveness of strategies for informing, educating, and involving patients.

Authors:  Angela Coulter; Jo Ellins
Journal:  BMJ       Date:  2007-07-07

4.  Variation in nephrologist visits to patients on hemodialysis across dialysis facilities and geographic locations.

Authors:  Kevin F Erickson; Kelvin B Tan; Wolfgang C Winkelmayer; Glenn M Chertow; Jay Bhattacharya
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 8.237

5.  Data and methods to facilitate delivery system reform: harnessing collective intelligence to learn from positive deviance.

Authors:  Harold S Luft
Journal:  Health Serv Res       Date:  2010-08-02       Impact factor: 3.402

6.  Exploring Attributes of High-Value Primary Care.

Authors:  Melora Simon; Niteesh K Choudhry; Jim Frankfort; David Margolius; Julia Murphy; Luis Paita; Thomas Wang; Arnold Milstein
Journal:  Ann Fam Med       Date:  2017-11       Impact factor: 5.166

7.  EPO adjustments in patients with elevated hemoglobin levels: provider practice patterns compared with recommended practice guidelines.

Authors:  Allan J Collins; James P Ebben; David T Gilbertson
Journal:  Am J Kidney Dis       Date:  2007-01       Impact factor: 8.860

8.  Early Trends Among Seven Recommendations From the Choosing Wisely Campaign.

Authors:  Alan Rosenberg; Abiy Agiro; Marc Gottlieb; John Barron; Peter Brady; Ying Liu; Cindy Li; Andrea DeVries
Journal:  JAMA Intern Med       Date:  2015-12       Impact factor: 21.873

9.  Cost-effectiveness analysis of intravenous ferumoxytol for the treatment of iron deficiency anemia in adult patients with non-dialysis-dependent chronic kidney disease in the USA.

Authors:  Naomi V Dahl; Robert F Kaper; William E Strauss; Frank A Corvino; Marko Zivkovic
Journal:  Clinicoecon Outcomes Res       Date:  2017-09-20

Review 10.  What methods are used to apply positive deviance within healthcare organisations? A systematic review.

Authors:  Ruth Baxter; Natalie Taylor; Ian Kellar; Rebecca Lawton
Journal:  BMJ Qual Saf       Date:  2015-11-20       Impact factor: 7.035

View more
  3 in total

1.  Value-Based Kidney Care: Aligning Metrics and Incentives to Improve the Health of People with Kidney Disease.

Authors:  Pranav S Garimella; Daniel E Weiner
Journal:  J Am Soc Nephrol       Date:  2019-11-14       Impact factor: 10.121

2.  Value-Based Care in Chronic Kidney Disease: Missing Albuminuria is a Missed Opportunity.

Authors:  Allison C Reaves; Daniel E Weiner
Journal:  Clin J Am Soc Nephrol       Date:  2021-12-30       Impact factor: 10.614

3.  Benchmark Method for Cost Computations Across Health Care Systems: Cost of Care per Patient per Day in Breast Cancer Care.

Authors:  Douglas W Blayney; Tina Seto; Nhat Hoang; Craig Lindquist; Allison W Kurian
Journal:  JCO Oncol Pract       Date:  2021-03-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.